The Influence ofHelicobacter pyloriEradication on the Gastric Mucosal Content of Epidermal Growth Factor, Transforming Growth Factor-a, and Their Common Receptor
- 1 January 1998
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 33 (3) , 271-275
- https://doi.org/10.1080/00365529850170856
Abstract
The relationship between the expression of epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) and that of their receptor (EGF-R) in the Helicobacter pylori-infected gastric mucosa has not been completely elucidated. The aim of this study was to examine the interplay between H. pylori colonization and gastric mucosal growth factor content. By means of a solid-phase enzyme-linked immunosorbent assay EGF, TGF-alpha, and EGF-R levels and interleukin-1beta (IL-1beta) content, which is considered a marker of chronic inflammation, were evaluated in the antral mucosa of 24 H. pylori-positive patients before and 8 weeks after eradication therapy. After therapy H. pylori was eradicated in 19 patients. The eradication was accompanied by a significant decrease in IL-1beta content and an increase in EGF and TGF-alpha levels. On the other hand, in the five patients in whom the bacterium was not eradicated EGF, TGF-alpha, and EGF-R levels were quite similar to those assayed before therapy, whereas IL-1beta content was still high. These results suggest that H. pylori exerts an inhibitory effect on the mucosal expression of EGF and TGF-alpha, which are likely involved in the gastric mucosa repair process.Keywords
This publication has 11 references indexed in Scilit:
- Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori.Gut, 1997
- Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis.Gut, 1996
- Successful Eradicating Treatment of Helicobacter Pylori in Patients with Chronic Gastritis: Gastric Les of Cytokines, Epidermal Growth Factor and Polyamines Before and After TherapyImmunopharmacology and Immunotoxicology, 1996
- The epidermal growth factor/transforming growth factor-?? family and their receptorsEuropean Journal of Gastroenterology & Hepatology, 1995
- Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humansDigestive Diseases and Sciences, 1995
- Mucosal Tumor Necrosis Factor-or, Interleukin-1/3, and Interleukin-8 Production in Patients with Helicobacter pylori InfectionScandinavian Journal of Gastroenterology, 1994
- Immunopathology of Ulcer DiseaseAnnals of the New York Academy of Sciences, 1993
- Interleukin-1 and interleukin-1 antagonismBlood, 1991
- Transforming growth factor α and epidermal growth factor levels in normal human gastrointestinal mucosaBritish Journal of Cancer, 1989
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951